Different ways to order SYLVANT® (siltuximab)
SYLVANT 100 MG NDC: 73090-420-01a |
SYLVANT 400 MG NDC: 73090-421-01a |
|||
---|---|---|---|---|
Authorized Dealer |
Phone Number |
Website | Item # | Item # |
ASD Healthcare | 800-746-6273 | 10253123 | 10253031 | |
Cardinal Health Specialty Distribution | 877-453-3972 | 5694179 | 5694187 | |
McKesson Plasma and Biologics | 877-625-2566 | 2883965 | 2883973 | |
McKesson Specialty Care Distribution | 800-482-6700 | 5016640 | 5016641 | |
Oncology Supply | 800-633-7555 | 10253087 | 10253059 |
aSYLVANT® National Drug Code Updated as of 2/19/21.
R.A.R.E.® can help*
R.A.R.E. (Recordati Access, Resources, and Engagement) is designed to make it easier for your patients to access and stay on treatment.
R.A.R.E. support may include
- Co-pay assistance
- Benefit investigations
- Prior Authorization and Appeals Support
Phone: 1-855-299-8844
Fax: 1-888-223-1746
*Eligibility requirements apply
For patients prescribed SYLVANT, R.A.R.E. can help connect your practice and patients with a variety of resources:
Access and reimbursement
support
- Insurance verification—Determining whether your patients’ insurance companies will cover SYLVANT and help with understanding their insurance benefits for SYLVANT
- Prior Authorizations/Appeals—Facilitating the prior authorization/appeals process by determining requirements, coordinating paperwork, and following up on the final decision
Financial assistance
- Co-pay assistance program—Assess your patient’s eligibility to participate and enroll them in the co-pay program
- Patient Assistance Program (PAP)—Help your patients access SYLVANT if they are eligible and do not have insurance or if underinsured
- Additional referrals—Refer your patients to outside assistance sources if appropriate
Personalized support for your patients while on SYLVANT therapy
The Patient Liaison (PL) is ready to connect with your patients who opt-in to the program to discuss SYLVANT and iMCD.
The PL Program* provides one-on-one support services at no additional cost to your patients.
*PL services are provided by Recordati Rare Diseases to help support patients while on SYLVANT therapy. Information provided by the PL Program is for educational purposes only and is not intended to replace the advice of the healthcare provider.The Patient Liaison will call enrolled patients to:
Provide education and answer questions about iMCD and SYLVANT
Help eligible patients access SYLVANT medication
Connect patients with other iMCD educational resources†
To get started, your patients can complete
the Program Enrollment Opt‑In Form
COMPLETE THE OPT-IN FORM
The PL will contact your patients upon receipt of the opt-in form.
Castleman Disease Collaborative
Network (CDCN)
The CDCN is a global initiative dedicated to accelerating research and treatment for Castleman disease.
Additional Tools
Dosing and Administration Guide
Learn more about the administration process, including preadministration laboratory testing here.
Infusion Guide
Familiarize yourself with the infusion process for SYLVANT.
NCCN/CDCN Guidelines
SYLVANT is guideline-preferred for all patients with iMCD, regardless of severity.
Patient Liaison Support
Personalized support is available to your patients while on SYLVANT therapy.
Abbreviations: CDCN, Castleman Disease Collaborative Network; NCCN, National Comprehensive Cancer Network.